# mHealth Intervention to Support Diabetes Medication Adherence

Study · id `cardio:ct-nct05006872` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05006872](<https://clinicaltrials.gov/study/NCT05006872>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05006872

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 742 participants.

## Technical summary

Registry record NCT05006872. Randomized; double masking; primary purpose supportive care. Start 2021-10-06 (actual); primary completion 2023-03-31 (actual). Results posted on 2025-02-28.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose supportive care
- Phase: Not applicable
- Enrolled: 742 participants (enrolled count; ClinicalTrials.gov record NCT05006872, source copy `cardio:ctgov-nct05006872-2025-02-28`, retrieved 2026-10-26)
- Started: 2021-10-06 (actual) (ClinicalTrials.gov record NCT05006872, source copy `cardio:ctgov-nct05006872-2025-02-28`, retrieved 2026-10-26)
- Primary completion: 2023-03-31 (actual) (ClinicalTrials.gov record NCT05006872, source copy `cardio:ctgov-nct05006872-2025-02-28`, retrieved 2026-10-26)
- Completion: 2023-04-30 (actual) (ClinicalTrials.gov record NCT05006872, source copy `cardio:ctgov-nct05006872-2025-02-28`, retrieved 2026-10-26)
- Results first posted: 2025-02-28 (ClinicalTrials.gov record NCT05006872, source copy `cardio:ctgov-nct05006872-2025-02-28`, retrieved 2026-10-26)
- Countries: Spain (ClinicalTrials.gov record NCT05006872, source copy `cardio:ctgov-nct05006872-2025-02-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05006872-2025-02-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: mHealth Intervention to Support Diabetes Medication Adherence
- Acronym: DIABE-TEXT
- Condition: Diabetes Mellitus, Type 2
- Intervention (Device): DIABE-TEXT
- Lead sponsor: Fundació d'investigació Sanitària de les Illes Balears
- Lead sponsor class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

## Provenance

Content hash: 1ba51114b9506ba72336d28d114a13f0f4b6dcbba8b7fb0d4b65883b3820c391
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
